Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs
Scribe Therapeutics files for $75 million IPO to test public appetite for early-stage biotechs
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Scribe Therapeutics, a biotech company focused on cardiovascular diseases, has filed for a $75 million IPO. The company, based in Alameda, uses gene-editing technology to fight cholesterol.
Coverage from Renaissance Capital, The Business Journals, Investing.com, Moomoo, and Endpoints News highlights Scribe Therapeutics' stockholder list, which includes Eli Lilly. The IPO will be listed on Nasdaq, but coverage does not yet specify when it will take place or how the public will respond.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 1h ago.
Quick answers
What is Scribe Therapeutics' focus?
Cardiovascular diseases
How much is Scribe Therapeutics seeking in its IPO?
$75 million
Who is a notable stockholder in Scribe Therapeutics?
Eli Lilly
Coverage (5)
- SCTX IPO News - Cardiovascular diseases biotech Scribe Therapeutics files for a $75 million IPO renaissancecapital.com · 1d ago
- Meet the gene-editing, cholesterol-fighting Alameda company looking for IPO riches The Business Journals · 1d ago
- Scribe Therapeutics files for proposed Nasdaq IPO By Investing.com Investing.com South Africa · 1d ago
- Scribe Therapeutics Stockholders Include Eli Lilly Moomoo · 1d ago
- Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs Endpoints News · 1d ago broke it first
People, places & organizations
Topics
Related trends
Korea Said to Prepare for Currency Flow From SK Hynix US Listing
South Korea is preparing for significant currency flows following SK Hynix's approved $29.4 billion share issue and Nasdaq ADR listing.
Sandwich chain Jersey Mike's files for IPO, reports 50% same-store sales growth in recent years
Blackstone-backed sandwich chain Jersey Mike's is moving toward a public listing on the NYSE following significant sales growth.
Stock futures are little changed after weak start to July trading; jobs report ahead: Live updates
Wall Street futures remain muted as investors pivot toward upcoming U.S. payrolls data and a global AI sector selloff.
Lime begins life as a public company after years of uncertainty
Uber-backed Lime has transitioned to a public company, raising $167 million in its initial public offering.
AOL, Vimeo owner Bending Spoons surges 39% in US market debut
Bending Spoons, the owner of AOL and Vimeo, saw its shares surge 39% during its U.S. market debut on the Nasdaq.
Stock Market Today: Stock Futures Slip as Investors Await Warsh Comments
Wall Street futures are slipping as investors anticipate comments from Warsh and the release of June jobs data.